중합효소 연쇄반응(PCR) 시장 분석 및 예측(-2035년) : 유형, 제품 유형, 서비스, 기술, 구성 요소, 용도, 프로세스, 최종 사용자, 솔루션, 제공 형태

The global Polymerase Chain Reaction Market is projected to grow from $15.2 billion in 2025 to $28.0 billion by 2035, at a compound annual growth rate (CAGR) of 6.4%. The Polymerase Chain Reaction (PCR) Market is moderately consolidated, with leading life science and molecular diagnostics companies focusing on expanding PCR platforms, assay portfolios, and automation capabilities. Market growth is driven by increasing demand for molecular diagnostics, infectious disease testing, oncology research, genetic analysis, and precision medicine. Continuous innovation in digital PCR, real-time PCR, and automated workflow solutions, along with strategic collaborations and product launches, is strengthening the competitive landscape. For instance, in January 2025, QIAGEN launched the QIAcuity High Multiplex Probe PCR Kit and QIAcuity Software 3.1, increasing its digital PCR platform's multiplexing capability from five to twelve targets, enabling deeper biological analysis and improving molecular research efficiency.

Based on Product, the Reagents and Consumables segment dominated the Polymerase Chain Reaction (PCR) market in 2025 due to their recurring use in every PCR workflow across clinical diagnostics, research, pharmaceutical development, and biotechnology applications. PCR reagents, including enzymes, primers, probes, nucleotides, and buffers, require frequent replenishment, generating continuous demand from laboratories worldwide. The increasing volume of molecular diagnostic testing, expanding genomics research, and rising adoption of PCR-based infectious disease and oncology testing have further strengthened the segment's leadership. Continuous product innovations, improved assay performance, and growing investments in life sciences research continue to support the dominance of reagents and consumables in the global PCR market.

Based on Type, the Digital PCR segment is projected to register the fastest growth during the forecast period, driven by its superior sensitivity, absolute nucleic acid quantification, and exceptional analytical precision compared with conventional and real-time PCR techniques. Digital PCR is increasingly utilized in oncology diagnostics, liquid biopsy, rare mutation detection, infectious disease testing, and cell and gene therapy research, where highly accurate molecular analysis is essential. Rising demand for precision medicine, expanding applications in clinical diagnostics, and increasing investments in advanced molecular testing are accelerating adoption. Continuous technological innovations, workflow automation, and improved assay capabilities are expected to further drive the rapid growth of the Digital PCR segment throughout the forecast period.

Geographical Overview

North America dominated the Polymerase Chain Reaction (PCR) market in 2025, supported by its advanced healthcare infrastructure, strong molecular diagnostics ecosystem, and substantial investments in genomics and life sciences research. The region benefits from the presence of leading PCR technology providers, well-established diagnostic laboratories, and extensive adoption of PCR-based testing across clinical diagnostics, infectious disease detection, oncology, and genetic testing. The United States accounts for the largest regional share owing to high healthcare expenditure, significant government funding for biomedical research, increasing demand for precision medicine, and the widespread use of advanced PCR platforms in pharmaceutical, biotechnology, and academic research institutions. Canada further contributes through expanding genomics research and supportive healthcare initiatives.

Asia-Pacific is projected to register the fastest growth during the forecast period, driven by rapidly expanding healthcare infrastructure, increasing adoption of molecular diagnostics, and growing investments in biotechnology and genomic research. Countries such as China, India, Japan, and South Korea are significantly increasing investments in clinical diagnostics, precision medicine, and infectious disease surveillance, accelerating the demand for advanced PCR technologies. Rising government support for healthcare modernization, expanding pharmaceutical and biotechnology industries, growing research activities, and increasing awareness of early disease diagnosis are further fueling market growth. Additionally, the expansion of diagnostic laboratories and improving access to advanced healthcare services are expected to strengthen the regional PCR market throughout the forecast period.

Key Trends and Drivers

Growing Adoption of Digital PCR and Advanced Molecular Diagnostics:

The Polymerase Chain Reaction (PCR) market is witnessing a strong trend toward the adoption of digital PCR (dPCR) and advanced molecular diagnostic technologies due to their superior sensitivity, precision, and absolute nucleic acid quantification capabilities. Digital PCR is increasingly being utilized in oncology, infectious disease detection, liquid biopsy, genetic testing, and cell and gene therapy research. Continuous advancements in automation, multiplexing, and integrated PCR platforms are improving workflow efficiency and diagnostic accuracy. Furthermore, the growing emphasis on precision medicine and early disease detection is accelerating the integration of advanced PCR technologies into clinical diagnostics and biomedical research worldwide.

Increasing Demand for Molecular Diagnostics and Precision Medicine:

The rising demand for molecular diagnostics and precision medicine is a major driver of the Polymerase Chain Reaction (PCR) market. Increasing prevalence of infectious diseases, cancer, and genetic disorders is driving the need for rapid, accurate, and highly sensitive diagnostic solutions. PCR technologies play a critical role in disease diagnosis, pathogen detection, biomarker identification, and genetic analysis, making them indispensable in modern healthcare. Additionally, growing investments in genomics research, expanding pharmaceutical and biotechnology activities, and increasing government support for advanced diagnostic infrastructure are further accelerating the adoption of PCR technologies across clinical and research applications.

Research Scope

• Estimates and forecasts the overall market size across type, application, and region.
• Provides detailed information and key takeaways on qualitative and quantitative trends, dynamics, business framework, competitive landscape, and company profiling.
• Identifies factors influencing market growth and challenges, opportunities, drivers, and restraints.
• Identifies factors that could limit company participation in international markets to help calibrate market share expectations and growth rates.
• Evaluates key development strategies like acquisitions, product launches, mergers, collaborations, business expansions, agreements, partnerships, and R&D activities.
• Analyzes smaller market segments strategically, focusing on their potential, growth patterns, and impact on the overall market.
• Outlines the competitive landscape, assessing business and corporate strategies to monitor and dissect competitive advancements.

Our research scope provides comprehensive market data, insights, and analysis across a variety of critical areas. We cover Local Market Analysis, assessing consumer demographics, purchasing behaviors, and market size within specific regions to identify growth opportunities. Our Local Competition Review offers a detailed evaluation of competitors, including their strengths, weaknesses, and market positioning. We also conduct Local Regulatory Reviews to ensure businesses comply with relevant laws and regulations. Industry Analysis provides an in-depth look at market dynamics, key players, and trends. Additionally, we offer Cross-Segmental Analysis to identify synergies between different market segments, as well as Production-Consumption and Demand-Supply Analysis to optimize supply chain efficiency. Our Import-Export Analysis helps businesses navigate global trade environments by evaluating trade flows and policies. These insights empower clients to make informed strategic decisions, mitigate risks, and capitalize on market opportunities.

TABLE OF CONTENTS

1 Executive Summary

• 1.1 Market Size and Forecast
• 1.2 Market Overview
• 1.3 Market Snapshot
• 1.4 Regional Snapshot
• 1.5 Strategic Recommendations
• 1.6 Analyst Notes

2 Market Highlights

• 2.1 Key Market Highlights by Type
• 2.2 Key Market Highlights by Product
• 2.3 Key Market Highlights by Services
• 2.4 Key Market Highlights by Technology
• 2.5 Key Market Highlights by Application
• 2.6 Key Market Highlights by End User
• 2.7 Key Market Highlights by Process
• 2.8 Key Market Highlights by Component
• 2.9 Key Market Highlights by Solutions
• 2.10 Key Market Highlights by Mode

3 Market Dynamics

• 3.1 Macroeconomic Analysis
• 3.2 Market Trends
• 3.3 Market Drivers
• 3.4 Market Opportunities
• 3.5 Market Restraints
• 3.6 CAGR Growth Analysis
• 3.7 Impact Analysis
• 3.8 Emerging Markets
• 3.9 Technology Roadmap
• 3.10 Strategic Frameworks
  • 3.10.1 PORTER's 5 Forces Model
  • 3.10.2 ANSOFF Matrix
  • 3.10.3 4P's Model
  • 3.10.4 PESTEL Analysis

4 Segment Analysis

• 4.1 Market Size & Forecast by Type (2020-2035)
  • 4.1.1 Conventional PCR
  • 4.1.2 Real-time PCR
  • 4.1.3 Digital PCR
  • 4.1.4 Others
• 4.2 Market Size & Forecast by Product (2020-2035)
  • 4.2.1 Instruments
  • 4.2.2 Reagents and Consumables
  • 4.2.3 Software
  • 4.2.4 Others
• 4.3 Market Size & Forecast by Services (2020-2035)
  • 4.3.1 Calibration Services
  • 4.3.2 Maintenance Services
  • 4.3.3 Training Services
  • 4.3.4 Others
• 4.4 Market Size & Forecast by Technology (2020-2035)
  • 4.4.1 Thermal Cyclers
  • 4.4.2 qPCR
  • 4.4.3 dPCR
  • 4.4.4 Others
• 4.5 Market Size & Forecast by Application (2020-2035)
  • 4.5.1 Clinical Diagnostics
  • 4.5.2 Research
  • 4.5.3 Forensics
  • 4.5.4 Environmental Testing
  • 4.5.5 Food Safety
  • 4.5.6 Others
• 4.6 Market Size & Forecast by End User (2020-2035)
  • 4.6.1 Hospitals and Diagnostic Centers
  • 4.6.2 Academic and Research Institutions
  • 4.6.3 Pharmaceutical and Biotechnology Companies
  • 4.6.4 Clinical Research Organizations
  • 4.6.5 Others
• 4.7 Market Size & Forecast by Process (2020-2035)
  • 4.7.1 Amplification
  • 4.7.2 Quantification
  • 4.7.3 Detection
  • 4.7.4 Others
• 4.8 Market Size & Forecast by Component (2020-2035)
  • 4.8.1 Enzymes
  • 4.8.2 Primers
  • 4.8.3 Buffers
  • 4.8.4 Nucleotides
  • 4.8.5 Others
• 4.9 Market Size & Forecast by Solutions (2020-2035)
  • 4.9.1 Standalone PCR Systems
  • 4.9.2 Integrated Systems
  • 4.9.3 Others
• 4.10 Market Size & Forecast by Mode (2020-2035)
  • 4.10.1 Automated
  • 4.10.2 Semi-automated
  • 4.10.3 Manual
  • 4.10.4 Others

5 Regional Analysis

• 5.1 Global Market Overview
• 5.2 North America Market Size (2020-2035)
  • 5.2.1 United States
    • 5.2.1.1 Type
    • 5.2.1.2 Product
    • 5.2.1.3 Services
    • 5.2.1.4 Technology
    • 5.2.1.5 Application
    • 5.2.1.6 End User
    • 5.2.1.7 Process
    • 5.2.1.8 Component
    • 5.2.1.9 Solutions
    • 5.2.1.10 Mode
  • 5.2.2 Canada
    • 5.2.2.1 Type
    • 5.2.2.2 Product
    • 5.2.2.3 Services
    • 5.2.2.4 Technology
    • 5.2.2.5 Application
    • 5.2.2.6 End User
    • 5.2.2.7 Process
    • 5.2.2.8 Component
    • 5.2.2.9 Solutions
    • 5.2.2.10 Mode
  • 5.2.3 Mexico
    • 5.2.3.1 Type
    • 5.2.3.2 Product
    • 5.2.3.3 Services
    • 5.2.3.4 Technology
    • 5.2.3.5 Application
    • 5.2.3.6 End User
    • 5.2.3.7 Process
    • 5.2.3.8 Component
    • 5.2.3.9 Solutions
    • 5.2.3.10 Mode
• 5.3 Latin America Market Size (2020-2035)
  • 5.3.1 Brazil
    • 5.3.1.1 Type
    • 5.3.1.2 Product
    • 5.3.1.3 Services
    • 5.3.1.4 Technology
    • 5.3.1.5 Application
    • 5.3.1.6 End User
    • 5.3.1.7 Process
    • 5.3.1.8 Component
    • 5.3.1.9 Solutions
    • 5.3.1.10 Mode
  • 5.3.2 Argentina
    • 5.3.2.1 Type
    • 5.3.2.2 Product
    • 5.3.2.3 Services
    • 5.3.2.4 Technology
    • 5.3.2.5 Application
    • 5.3.2.6 End User
    • 5.3.2.7 Process
    • 5.3.2.8 Component
    • 5.3.2.9 Solutions
    • 5.3.2.10 Mode
  • 5.3.3 Rest of Latin America
    • 5.3.3.1 Type
    • 5.3.3.2 Product
    • 5.3.3.3 Services
    • 5.3.3.4 Technology
    • 5.3.3.5 Application
    • 5.3.3.6 End User
    • 5.3.3.7 Process
    • 5.3.3.8 Component
    • 5.3.3.9 Solutions
    • 5.3.3.10 Mode
• 5.4 Asia-Pacific Market Size (2020-2035)
  • 5.4.1 China
    • 5.4.1.1 Type
    • 5.4.1.2 Product
    • 5.4.1.3 Services
    • 5.4.1.4 Technology
    • 5.4.1.5 Application
    • 5.4.1.6 End User
    • 5.4.1.7 Process
    • 5.4.1.8 Component
    • 5.4.1.9 Solutions
    • 5.4.1.10 Mode
  • 5.4.2 India
    • 5.4.2.1 Type
    • 5.4.2.2 Product
    • 5.4.2.3 Services
    • 5.4.2.4 Technology
    • 5.4.2.5 Application
    • 5.4.2.6 End User
    • 5.4.2.7 Process
    • 5.4.2.8 Component
    • 5.4.2.9 Solutions
    • 5.4.2.10 Mode
  • 5.4.3 South Korea
    • 5.4.3.1 Type
    • 5.4.3.2 Product
    • 5.4.3.3 Services
    • 5.4.3.4 Technology
    • 5.4.3.5 Application
    • 5.4.3.6 End User
    • 5.4.3.7 Process
    • 5.4.3.8 Component
    • 5.4.3.9 Solutions
    • 5.4.3.10 Mode
  • 5.4.4 Japan
    • 5.4.4.1 Type
    • 5.4.4.2 Product
    • 5.4.4.3 Services
    • 5.4.4.4 Technology
    • 5.4.4.5 Application
    • 5.4.4.6 End User
    • 5.4.4.7 Process
    • 5.4.4.8 Component
    • 5.4.4.9 Solutions
    • 5.4.4.10 Mode
  • 5.4.5 Australia
    • 5.4.5.1 Type
    • 5.4.5.2 Product
    • 5.4.5.3 Services
    • 5.4.5.4 Technology
    • 5.4.5.5 Application
    • 5.4.5.6 End User
    • 5.4.5.7 Process
    • 5.4.5.8 Component
    • 5.4.5.9 Solutions
    • 5.4.5.10 Mode
  • 5.4.6 Taiwan
    • 5.4.6.1 Type
    • 5.4.6.2 Product
    • 5.4.6.3 Services
    • 5.4.6.4 Technology
    • 5.4.6.5 Application
    • 5.4.6.6 End User
    • 5.4.6.7 Process
    • 5.4.6.8 Component
    • 5.4.6.9 Solutions
    • 5.4.6.10 Mode
  • 5.4.7 Rest of APAC
    • 5.4.7.1 Type
    • 5.4.7.2 Product
    • 5.4.7.3 Services
    • 5.4.7.4 Technology
    • 5.4.7.5 Application
    • 5.4.7.6 End User
    • 5.4.7.7 Process
    • 5.4.7.8 Component
    • 5.4.7.9 Solutions
    • 5.4.7.10 Mode
• 5.5 Europe Market Size (2020-2035)
  • 5.5.1 Germany
    • 5.5.1.1 Type
    • 5.5.1.2 Product
    • 5.5.1.3 Services
    • 5.5.1.4 Technology
    • 5.5.1.5 Application
    • 5.5.1.6 End User
    • 5.5.1.7 Process
    • 5.5.1.8 Component
    • 5.5.1.9 Solutions
    • 5.5.1.10 Mode
  • 5.5.2 France
    • 5.5.2.1 Type
    • 5.5.2.2 Product
    • 5.5.2.3 Services
    • 5.5.2.4 Technology
    • 5.5.2.5 Application
    • 5.5.2.6 End User
    • 5.5.2.7 Process
    • 5.5.2.8 Component
    • 5.5.2.9 Solutions
    • 5.5.2.10 Mode
  • 5.5.3 United Kingdom
    • 5.5.3.1 Type
    • 5.5.3.2 Product
    • 5.5.3.3 Services
    • 5.5.3.4 Technology
    • 5.5.3.5 Application
    • 5.5.3.6 End User
    • 5.5.3.7 Process
    • 5.5.3.8 Component
    • 5.5.3.9 Solutions
    • 5.5.3.10 Mode
  • 5.5.4 Spain
    • 5.5.4.1 Type
    • 5.5.4.2 Product
    • 5.5.4.3 Services
    • 5.5.4.4 Technology
    • 5.5.4.5 Application
    • 5.5.4.6 End User
    • 5.5.4.7 Process
    • 5.5.4.8 Component
    • 5.5.4.9 Solutions
    • 5.5.4.10 Mode
  • 5.5.5 Italy
    • 5.5.5.1 Type
    • 5.5.5.2 Product
    • 5.5.5.3 Services
    • 5.5.5.4 Technology
    • 5.5.5.5 Application
    • 5.5.5.6 End User
    • 5.5.5.7 Process
    • 5.5.5.8 Component
    • 5.5.5.9 Solutions
    • 5.5.5.10 Mode
  • 5.5.6 Rest of Europe
    • 5.5.6.1 Type
    • 5.5.6.2 Product
    • 5.5.6.3 Services
    • 5.5.6.4 Technology
    • 5.5.6.5 Application
    • 5.5.6.6 End User
    • 5.5.6.7 Process
    • 5.5.6.8 Component
    • 5.5.6.9 Solutions
    • 5.5.6.10 Mode
• 5.6 Middle East & Africa Market Size (2020-2035)
  • 5.6.1 Saudi Arabia
    • 5.6.1.1 Type
    • 5.6.1.2 Product
    • 5.6.1.3 Services
    • 5.6.1.4 Technology
    • 5.6.1.5 Application
    • 5.6.1.6 End User
    • 5.6.1.7 Process
    • 5.6.1.8 Component
    • 5.6.1.9 Solutions
    • 5.6.1.10 Mode
  • 5.6.2 United Arab Emirates
    • 5.6.2.1 Type
    • 5.6.2.2 Product
    • 5.6.2.3 Services
    • 5.6.2.4 Technology
    • 5.6.2.5 Application
    • 5.6.2.6 End User
    • 5.6.2.7 Process
    • 5.6.2.8 Component
    • 5.6.2.9 Solutions
    • 5.6.2.10 Mode
  • 5.6.3 South Africa
    • 5.6.3.1 Type
    • 5.6.3.2 Product
    • 5.6.3.3 Services
    • 5.6.3.4 Technology
    • 5.6.3.5 Application
    • 5.6.3.6 End User
    • 5.6.3.7 Process
    • 5.6.3.8 Component
    • 5.6.3.9 Solutions
    • 5.6.3.10 Mode
  • 5.6.4 Sub-Saharan Africa
    • 5.6.4.1 Type
    • 5.6.4.2 Product
    • 5.6.4.3 Services
    • 5.6.4.4 Technology
    • 5.6.4.5 Application
    • 5.6.4.6 End User
    • 5.6.4.7 Process
    • 5.6.4.8 Component
    • 5.6.4.9 Solutions
    • 5.6.4.10 Mode
  • 5.6.5 Rest of MEA
    • 5.6.5.1 Type
    • 5.6.5.2 Product
    • 5.6.5.3 Services
    • 5.6.5.4 Technology
    • 5.6.5.5 Application
    • 5.6.5.6 End User
    • 5.6.5.7 Process
    • 5.6.5.8 Component
    • 5.6.5.9 Solutions
    • 5.6.5.10 Mode

6 Market Strategy

• 6.1 Demand-Supply Gap Analysis
• 6.2 Trade & Logistics Constraints
• 6.3 Price-Cost-Margin Trends
• 6.4 Market Penetration
• 6.5 Consumer Analysis
• 6.6 Regulatory Snapshot

7 Competitive Intelligence

• 7.1 Market Positioning
• 7.2 Market Share
• 7.3 Competition Benchmarking
• 7.4 Top Company Strategies

8 Company Profiles

• 8.1 Thermo Fisher Scientific
  • 8.1.1 Overview
  • 8.1.2 Product Summary
  • 8.1.3 Financial Performance
  • 8.1.4 SWOT Analysis
• 8.2 Bio-Rad Laboratories
  • 8.2.1 Overview
  • 8.2.2 Product Summary
  • 8.2.3 Financial Performance
  • 8.2.4 SWOT Analysis
• 8.3 Roche Diagnostics
  • 8.3.1 Overview
  • 8.3.2 Product Summary
  • 8.3.3 Financial Performance
  • 8.3.4 SWOT Analysis
• 8.4 QIAGEN
  • 8.4.1 Overview
  • 8.4.2 Product Summary
  • 8.4.3 Financial Performance
  • 8.4.4 SWOT Analysis
• 8.5 Agilent Technologies
  • 8.5.1 Overview
  • 8.5.2 Product Summary
  • 8.5.3 Financial Performance
  • 8.5.4 SWOT Analysis
• 8.6 Takara Bio
  • 8.6.1 Overview
  • 8.6.2 Product Summary
  • 8.6.3 Financial Performance
  • 8.6.4 SWOT Analysis
• 8.7 Merck KGaA
  • 8.7.1 Overview
  • 8.7.2 Product Summary
  • 8.7.3 Financial Performance
  • 8.7.4 SWOT Analysis
• 8.8 Illumina
  • 8.8.1 Overview
  • 8.8.2 Product Summary
  • 8.8.3 Financial Performance
  • 8.8.4 SWOT Analysis
• 8.9 PerkinElmer
  • 8.9.1 Overview
  • 8.9.2 Product Summary
  • 8.9.3 Financial Performance
  • 8.9.4 SWOT Analysis
• 8.10 Becton Dickinson
  • 8.10.1 Overview
  • 8.10.2 Product Summary
  • 8.10.3 Financial Performance
  • 8.10.4 SWOT Analysis
• 8.11 Promega Corporation
  • 8.11.1 Overview
  • 8.11.2 Product Summary
  • 8.11.3 Financial Performance
  • 8.11.4 SWOT Analysis
• 8.12 Eppendorf
  • 8.12.1 Overview
  • 8.12.2 Product Summary
  • 8.12.3 Financial Performance
  • 8.12.4 SWOT Analysis
• 8.13 Analytik Jena
  • 8.13.1 Overview
  • 8.13.2 Product Summary
  • 8.13.3 Financial Performance
  • 8.13.4 SWOT Analysis
• 8.14 Fluidigm Corporation
  • 8.14.1 Overview
  • 8.14.2 Product Summary
  • 8.14.3 Financial Performance
  • 8.14.4 SWOT Analysis
• 8.15 LGC Limited
  • 8.15.1 Overview
  • 8.15.2 Product Summary
  • 8.15.3 Financial Performance
  • 8.15.4 SWOT Analysis
• 8.16 Abbott Laboratories
  • 8.16.1 Overview
  • 8.16.2 Product Summary
  • 8.16.3 Financial Performance
  • 8.16.4 SWOT Analysis
• 8.17 Danaher Corporation
  • 8.17.1 Overview
  • 8.17.2 Product Summary
  • 8.17.3 Financial Performance
  • 8.17.4 SWOT Analysis
• 8.18 Biomerieux
  • 8.18.1 Overview
  • 8.18.2 Product Summary
  • 8.18.3 Financial Performance
  • 8.18.4 SWOT Analysis
• 8.19 GE Healthcare
  • 8.19.1 Overview
  • 8.19.2 Product Summary
  • 8.19.3 Financial Performance
  • 8.19.4 SWOT Analysis
• 8.20 Cepheid
  • 8.20.1 Overview
  • 8.20.2 Product Summary
  • 8.20.3 Financial Performance
  • 8.20.4 SWOT Analysis

9 About Us

• 9.1 About Us
• 9.2 Research Methodology
• 9.3 Research Workflow
• 9.4 Consulting Services
• 9.5 Our Clients
• 9.6 Client Testimonials
• 9.7 Contact Us